BC Platforms Advances BC|RQUEST to Revolutionize Drug Discovery and Development

BC Platforms Advances BC|RQUEST to Revolutionize Drug Discovery and Development

Groundbreaking Software Provides Compliant Access to a Catchment of over 70 Million Patients in a Global Network

13 July 2023 - Zurich, Switzerland - BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces a new release of BC|RQUEST, a groundbreaking software update designed to revolutionize drug development and discovery. This unique global federated clinical and genomic network enables secure and compliant access to clinical data, while significantly enhancing the speed and effectiveness of clinical trials.

"BC|RQUEST represents a significant advancement in clinical research capabilities, helping to drive life sciences innovation globally," said Tero Silvola, CEO of BC Platforms. "With access to an extensive patient pool and accelerated clinical trials, we are dedicated to improving the lives of patients worldwide through groundbreaking discoveries and innovative solutions. Together with advances in our data partner network, which has a footprint including networks of major hospital and biobanks across six continents, we continue to lead in real-world-data federation technology and services."

BC|RQUEST’s Key Features and Benefits:

Unparalleled Patient Reach: BC|RQUEST provides researchers with access to an extensive catchment of over 70 million patients in a global network. This enables valuable insights and breakthroughs tailored to diverse patient populations, promoting advancements in medical research.

Secure Trusted Research Environment: Operating within a trusted research environment, BC|RQUEST ensures strict compliance with GDPR and HIPAA regulations. The software guarantees secure data processing and analysis, facilitating seamless collaboration between biobanks and external researchers.

Accelerated Clinical Trials: By streamlining operations, BC|RQUEST expedites the clinical trial process, leading to faster approvals and improved patient outcomes. The software optimizes efficiency and enhances the overall success rate of clinical trials.

Efficient Data Request and Approval: BC|RQUEST offers a user-friendly interface that serves as a comprehensive portal for data requests and approvals. Researchers can utilize the cohort search function to discover relevant data based on specific inclusion and exclusion criteria. Once approved, users gain access to the requested data through the BC Platforms Trusted Collaboration Environment.

For more information about BC|RQUEST and its capabilities, please visit the BC Platforms website at bcrquest.com or contact us at bcplatforms.com/contact/.